Wegener granulomatosis: an analysis of 158 patients
…, RY Leavitt, CW Hallahan, RS Lebovics… - Annals of internal …, 1992 - acpjournals.org
▪ Objective: To prospectively study the clinical features, pathophysiology, treatment, and
prognosis of Wegener granulomatosis. ▪ Design: Of the 180 patients with Wegener …
prognosis of Wegener granulomatosis. ▪ Design: Of the 180 patients with Wegener …
Clinical features and therapeutic management of subglottic stenosis in patients with Wegener's granulomatosis
…, AS Fauci, RS Lebovics - … : Official Journal of …, 1996 - Wiley Online Library
Objective. To determine the clinical features and optimal treatment of subglottic stenosis (SGS)
in patients with Wegener's granulomatosis (WG). Methods. Review of 43 patients with …
in patients with Wegener's granulomatosis (WG). Methods. Review of 43 patients with …
The management of subglottic stenosis in patients with Wegener's granulomatosis
RS Lebovics, GS Hoffman, RY Leavitt… - The …, 1992 - Wiley Online Library
Wegener's granulomatosis (WG) is a multisystem inflammatory disease characterized by
vasculitis, granuloma formation, and necrosis. Among 158 patients treated at the National …
vasculitis, granuloma formation, and necrosis. Among 158 patients treated at the National …
Timely airway stenting improves survival in patients with malignant central airway obstruction
SS Razi, RS Lebovics, G Schwartz, M Sancheti… - The Annals of thoracic …, 2010 - Elsevier
BACKGROUND: The survival of patients with malignant central airway obstruction is very
limited. Although airway stenting results in significant palliation of symptoms, data regarding …
limited. Although airway stenting results in significant palliation of symptoms, data regarding …
Treatment of benign tracheal stenosis using endoluminal spray cryotherapy
…, AM Al-Ayoubi, W Raad, RS Lebovics - … –Head & Neck …, 2016 - jamanetwork.com
Importance Tracheal stenosis is a debilitating disorder with heterogeneity in terms of disease
characteristics and management. Repeated recurrences substantially alter patients’ quality …
characteristics and management. Repeated recurrences substantially alter patients’ quality …
Effectiveness of rituximab for the otolaryngologic manifestations of granulomatosis with polyangiitis (Wegener's)
L Lally, RS Lebovics, WT Huang… - Arthritis Care & …, 2014 - Wiley Online Library
Objective Ear, nose, and throat (ENT) involvement is the most prevalent manifestation of
granulomatosis with polyangiitis (Wegener's) (GPA) and correlates with permanent damage and …
granulomatosis with polyangiitis (Wegener's) (GPA) and correlates with permanent damage and …
Circumferential three-dimensional–printed tracheal grafts: research model feasibility and early results
…, A Ayub, W Raad, AM Al-Ayoubi, RS Lebovics - The Annals of Thoracic …, 2017 - Elsevier
Background Methods for tracheal graft research have presented persistent challenges to
investigators, and three-dimensional (3D)–printed biosynthetic grafts offer one potential …
investigators, and three-dimensional (3D)–printed biosynthetic grafts offer one potential …
Human olfactory neuroepithelial cells: tyrosine phosphorylation and process extension are increased by the combination of IL-1β, IL-6, NGF, and bFGF
…, J Basaric-Keys, Y Li, DS Lester, RS Lebovics… - Experimental …, 1996 - Elsevier
Olfactory neuroepithelial cells (ONC) grown from biopsies of human donors are a novel cell
culture system that may facilitate studies into normal and disease-related human …
culture system that may facilitate studies into normal and disease-related human …
Reconstruction of anterior tracheal defects using a bioengineered graft in a porcine model
…, SS Rehmani, CF Sinclair, RS Lebovics… - The Annals of Thoracic …, 2017 - Elsevier
Background Reconstruction of long-segment tracheal defects can be challenging and a
suitable tracheal substitute remains lacking. We sought to create a bioengineered tracheal graft …
suitable tracheal substitute remains lacking. We sought to create a bioengineered tracheal graft …
Treatment of locally advanced cancer of the head and neck with 5′-iododeoxyuridine and hyperfractionated radiation therapy: measurement of cell labeling and …
AH Epstein, RS Lebovics, T Goffman… - JNCI: Journal of the …, 1994 - academic.oup.com
Background: The halogenated pyrimidines 5'-iododeoxyuridine (IdUrd) and 5'-bromodeoxyuridine
(BrdUrd) are under active study as radiation sensitizers for a variety of malignancies. …
(BrdUrd) are under active study as radiation sensitizers for a variety of malignancies. …